

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.61107280 |
| 2 | synaptic vesicle maturation (GO:0016188) | 5.24062693 |
| 3 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.14952936 |
| 4 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 5.04616289 |
| 5 | locomotory exploration behavior (GO:0035641) | 4.87828483 |
| 6 | vocalization behavior (GO:0071625) | 4.49871075 |
| 7 | synaptic vesicle exocytosis (GO:0016079) | 4.32166275 |
| 8 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.30622804 |
| 9 | negative regulation of cell killing (GO:0031342) | 4.30622804 |
| 10 | glutamate secretion (GO:0014047) | 4.21953303 |
| 11 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.17416535 |
| 12 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.11287072 |
| 13 | protein localization to synapse (GO:0035418) | 4.08748004 |
| 14 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.07689839 |
| 15 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 4.07443780 |
| 16 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.97295129 |
| 17 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.93122957 |
| 18 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.84624206 |
| 19 | neurotransmitter secretion (GO:0007269) | 3.80932692 |
| 20 | regulation of synaptic vesicle transport (GO:1902803) | 3.79817301 |
| 21 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.75772860 |
| 22 | regulation of synapse structural plasticity (GO:0051823) | 3.71698358 |
| 23 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.67201039 |
| 24 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 3.64197924 |
| 25 | exploration behavior (GO:0035640) | 3.58948195 |
| 26 | cellular potassium ion homeostasis (GO:0030007) | 3.54678077 |
| 27 | positive regulation of membrane potential (GO:0045838) | 3.51502856 |
| 28 | gamma-aminobutyric acid transport (GO:0015812) | 3.50109589 |
| 29 | layer formation in cerebral cortex (GO:0021819) | 3.49502285 |
| 30 | dendritic spine morphogenesis (GO:0060997) | 3.48254618 |
| 31 | tolerance induction (GO:0002507) | 3.48031120 |
| 32 | neuronal action potential propagation (GO:0019227) | 3.44746078 |
| 33 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.43834966 |
| 34 | sodium ion export (GO:0071436) | 3.43222007 |
| 35 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.41059562 |
| 36 | synaptic transmission, glutamatergic (GO:0035249) | 3.40396622 |
| 37 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.39505712 |
| 38 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 3.37777790 |
| 39 | long-term memory (GO:0007616) | 3.35725609 |
| 40 | modulation by symbiont of host immune response (GO:0052553) | 3.34029451 |
| 41 | positive regulation by symbiont of host defense response (GO:0052509) | 3.34029451 |
| 42 | modulation by symbiont of host defense response (GO:0052031) | 3.34029451 |
| 43 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 3.34029451 |
| 44 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 3.34029451 |
| 45 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 3.34029451 |
| 46 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.32135611 |
| 47 | neuron-neuron synaptic transmission (GO:0007270) | 3.31947564 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.28148482 |
| 49 | regulation of gamma-delta T cell activation (GO:0046643) | 3.28134610 |
| 50 | glutamate receptor signaling pathway (GO:0007215) | 3.27064978 |
| 51 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.26490936 |
| 52 | regulation of postsynaptic membrane potential (GO:0060078) | 3.23056691 |
| 53 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.19833541 |
| 54 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.17822992 |
| 55 | neurotransmitter transport (GO:0006836) | 3.17075525 |
| 56 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.17027329 |
| 57 | activation of protein kinase A activity (GO:0034199) | 3.16605332 |
| 58 | prepulse inhibition (GO:0060134) | 3.16564845 |
| 59 | behavioral response to cocaine (GO:0048148) | 3.14487046 |
| 60 | regulation of synaptic plasticity (GO:0048167) | 3.14034775 |
| 61 | neuromuscular process controlling balance (GO:0050885) | 3.10146901 |
| 62 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.09543746 |
| 63 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.09301572 |
| 64 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.08788004 |
| 65 | positive regulation of neurotransmitter transport (GO:0051590) | 3.07870118 |
| 66 | neuron cell-cell adhesion (GO:0007158) | 3.03791542 |
| 67 | glycine transport (GO:0015816) | 3.03757055 |
| 68 | G-protein coupled acetylcholine receptor signaling pathway (GO:0007213) | 3.02183854 |
| 69 | neuromuscular process controlling posture (GO:0050884) | 3.01111695 |
| 70 | proline transport (GO:0015824) | 2.99782113 |
| 71 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.98281521 |
| 72 | chemosensory behavior (GO:0007635) | 2.97857069 |
| 73 | regulation of female receptivity (GO:0045924) | 2.97525703 |
| 74 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.97280472 |
| 75 | response to histamine (GO:0034776) | 2.97105849 |
| 76 | signal complex assembly (GO:0007172) | 2.95942674 |
| 77 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.95871547 |
| 78 | activated T cell proliferation (GO:0050798) | 2.95738328 |
| 79 | dopamine receptor signaling pathway (GO:0007212) | 2.95716027 |
| 80 | regulation of gamma-delta T cell differentiation (GO:0045586) | 2.95386366 |
| 81 | striatum development (GO:0021756) | 2.95139781 |
| 82 | synaptic transmission, dopaminergic (GO:0001963) | 2.93362505 |
| 83 | regulation of ARF protein signal transduction (GO:0032012) | 2.92044708 |
| 84 | long-term synaptic potentiation (GO:0060291) | 2.91937685 |
| 85 | regulation of neurotransmitter levels (GO:0001505) | 2.91720714 |
| 86 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.90727260 |
| 87 | cilium or flagellum-dependent cell motility (GO:0001539) | 2.90039188 |
| 88 | membrane hyperpolarization (GO:0060081) | 2.89886749 |
| 89 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.89211896 |
| 90 | regulation of vesicle fusion (GO:0031338) | 2.88339852 |
| 91 | behavioral fear response (GO:0001662) | 2.86741719 |
| 92 | behavioral defense response (GO:0002209) | 2.86741719 |
| 93 | rhodopsin mediated signaling pathway (GO:0016056) | 2.86481458 |
| 94 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.85629610 |
| 95 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.85373576 |
| 96 | regulation of neurotransmitter secretion (GO:0046928) | 2.83762874 |
| 97 | auditory behavior (GO:0031223) | 2.83396448 |
| 98 | positive regulation of synapse maturation (GO:0090129) | 2.82706113 |
| 99 | transmission of nerve impulse (GO:0019226) | 2.80922244 |
| 100 | positive regulation of mast cell activation (GO:0033005) | 2.79240512 |
| 101 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.79030975 |
| 102 | positive regulation of neurotransmitter secretion (GO:0001956) | 2.78476851 |
| 103 | response to auditory stimulus (GO:0010996) | 2.75717277 |
| 104 | cell communication by electrical coupling (GO:0010644) | 2.75614980 |
| 105 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.75607651 |
| 106 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.75606687 |
| 107 | response to peptidoglycan (GO:0032494) | 2.75419977 |
| 108 | cellular sodium ion homeostasis (GO:0006883) | 2.74207043 |
| 109 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.72281775 |
| 110 | female mating behavior (GO:0060180) | 2.71724792 |
| 111 | negative regulation of T cell mediated immunity (GO:0002710) | 2.70849105 |
| 112 | mating behavior (GO:0007617) | 2.70560134 |
| 113 | retinal cone cell development (GO:0046549) | 2.70216796 |
| 114 | fear response (GO:0042596) | 2.69534777 |
| 115 | axonemal dynein complex assembly (GO:0070286) | 2.67792298 |
| 116 | regulation of neurotransmitter transport (GO:0051588) | 2.66911131 |
| 117 | regulation of regulated secretory pathway (GO:1903305) | 2.66103976 |
| 118 | neuronal ion channel clustering (GO:0045161) | 2.64993863 |
| 119 | membrane depolarization (GO:0051899) | 2.64112355 |
| 120 | neuron recognition (GO:0008038) | 2.63870719 |
| 121 | negative regulation of leukocyte mediated immunity (GO:0002704) | 2.63763808 |
| 122 | positive regulation of synaptic transmission (GO:0050806) | 2.60924669 |
| 123 | long term synaptic depression (GO:0060292) | 2.60864585 |
| 124 | neutrophil activation involved in immune response (GO:0002283) | 2.59461801 |
| 125 | cellular extravasation (GO:0045123) | 2.59291645 |
| 126 | regulation of glutamate secretion (GO:0014048) | 2.59290647 |
| 127 | synaptic vesicle endocytosis (GO:0048488) | 2.58509406 |
| 128 | regulation of dendritic spine development (GO:0060998) | 2.57882647 |
| 129 | dendritic spine organization (GO:0097061) | 2.57801162 |
| 130 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.56927048 |
| 131 | L-amino acid import (GO:0043092) | 2.56861765 |
| 132 | dendrite morphogenesis (GO:0048813) | 2.56692805 |
| 133 | vesicle transport along microtubule (GO:0047496) | 2.55554884 |
| 134 | neuromuscular process (GO:0050905) | 2.55509759 |
| 135 | positive regulation of vesicle fusion (GO:0031340) | 2.53670392 |
| 136 | germinal center formation (GO:0002467) | 2.52927679 |
| 137 | regulation of mast cell degranulation (GO:0043304) | 2.48111102 |
| 138 | mannose metabolic process (GO:0006013) | 2.46478276 |
| 139 | positive regulation of regulated secretory pathway (GO:1903307) | 2.45586743 |
| 140 | detection of other organism (GO:0098543) | 2.44725920 |
| 141 | motile cilium assembly (GO:0044458) | 2.43782759 |
| 142 | microglial cell activation (GO:0001774) | 2.40827986 |
| 143 | detection of bacterium (GO:0016045) | 2.39985871 |
| 144 | negative regulation of immunoglobulin mediated immune response (GO:0002890) | 2.39705719 |
| 145 | negative regulation of B cell mediated immunity (GO:0002713) | 2.39705719 |
| 146 | membrane repolarization during cardiac muscle cell action potential (GO:0086013) | 2.38409062 |
| 147 | negative regulation of interleukin-12 production (GO:0032695) | 2.37979859 |
| 148 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.36899806 |
| 149 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.36012388 |
| 150 | myeloid cell activation involved in immune response (GO:0002275) | 2.35417142 |
| 151 | positive regulation of Rap GTPase activity (GO:0032854) | 2.33919924 |
| 152 | regulation of leukocyte degranulation (GO:0043300) | 2.32882329 |
| 153 | regulation of mast cell activation (GO:0033003) | 2.31692896 |
| 154 | positive regulation of mast cell degranulation (GO:0043306) | 2.30899049 |
| 155 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.30899049 |
| 156 | B cell receptor signaling pathway (GO:0050853) | 2.30565890 |
| 157 | interferon-gamma secretion (GO:0072643) | 2.30542061 |
| 158 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.29442056 |
| 159 | macrophage activation (GO:0042116) | 2.29282327 |
| 160 | neutrophil activation (GO:0042119) | 2.29206234 |
| 161 | negative regulation of toll-like receptor signaling pathway (GO:0034122) | 2.26978068 |
| 162 | response to muramyl dipeptide (GO:0032495) | 2.24767393 |
| 163 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.24064031 |
| 164 | response to host immune response (GO:0052572) | 2.24064031 |
| 165 | regulation of T-helper 2 cell differentiation (GO:0045628) | 2.23847135 |
| 166 | peptidyl-tyrosine autophosphorylation (GO:0038083) | 2.22174682 |
| 167 | regulation of ARF GTPase activity (GO:0032312) | 2.20890353 |
| 168 | potassium ion import (GO:0010107) | 2.19222719 |
| 169 | cerebellar granule cell differentiation (GO:0021707) | 2.18968922 |
| 170 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.18719324 |
| 171 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.18110539 |
| 172 | positive regulation of CREB transcription factor activity (GO:0032793) | 2.17320778 |
| 173 | actin filament polymerization (GO:0030041) | 2.17186408 |
| 174 | T cell selection (GO:0045058) | 2.15500211 |
| 175 | negative thymic T cell selection (GO:0045060) | 2.14547901 |
| 176 | regulation of synapse maturation (GO:0090128) | 2.13538778 |
| 177 | membrane repolarization during action potential (GO:0086011) | 2.12238187 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.67088767 |
| 2 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.86447570 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.76171975 |
| 4 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.73733779 |
| 5 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.60950697 |
| 6 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.55872739 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.53742856 |
| 8 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.50280515 |
| 9 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.44485793 |
| 10 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.42232657 |
| 11 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.42232657 |
| 12 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.41597087 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.37775736 |
| 14 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 2.32571603 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.28985108 |
| 16 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.16269445 |
| 17 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.15923052 |
| 18 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.15114666 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.13398198 |
| 20 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 2.13027828 |
| 21 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 2.12572270 |
| 22 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.10029574 |
| 23 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 2.05333580 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.03181202 |
| 25 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.00935738 |
| 26 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.93716600 |
| 27 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.89680844 |
| 28 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.88041716 |
| 29 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.81891000 |
| 30 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.79568108 |
| 31 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.75538226 |
| 32 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.72778474 |
| 33 | SPI1_23127762_ChIP-Seq_K562_Human | 1.68239597 |
| 34 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 1.67073830 |
| 35 | P68_20966046_ChIP-Seq_HELA_Human | 1.66941073 |
| 36 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.62652569 |
| 37 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.62393577 |
| 38 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.62361330 |
| 39 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.59674967 |
| 40 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.55971281 |
| 41 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.55834817 |
| 42 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.55826760 |
| 43 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.52388615 |
| 44 | GATA1_19941826_ChIP-Seq_K562_Human | 1.51196110 |
| 45 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.49167531 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.48900886 |
| 47 | BCL6_27268052_Chip-Seq_Bcells_Human | 1.48389972 |
| 48 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.47105168 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.44210191 |
| 50 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.43989108 |
| 51 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.42905558 |
| 52 | * SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.42645436 |
| 53 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.41617470 |
| 54 | * TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.37733779 |
| 55 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.35358462 |
| 56 | MAF_26560356_Chip-Seq_TH1_Human | 1.34426607 |
| 57 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.34351319 |
| 58 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.32955635 |
| 59 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.31674365 |
| 60 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 1.30902075 |
| 61 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.27886660 |
| 62 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 1.27285826 |
| 63 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.26507018 |
| 64 | OCT4_19829295_ChIP-Seq_ESCs_Human | 1.26291414 |
| 65 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.25896892 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25757051 |
| 67 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.25569795 |
| 68 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.24723213 |
| 69 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.24500738 |
| 70 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.23834219 |
| 71 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.23699016 |
| 72 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.22399489 |
| 73 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.22274399 |
| 74 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.21954142 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.21087168 |
| 76 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.20950484 |
| 77 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.20875287 |
| 78 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.19704600 |
| 79 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.19426822 |
| 80 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.19426198 |
| 81 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.19343205 |
| 82 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.19175584 |
| 83 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.18464628 |
| 84 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17636525 |
| 85 | AR_19668381_ChIP-Seq_PC3_Human | 1.17598706 |
| 86 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.17257856 |
| 87 | E2F1_20622854_ChIP-Seq_HELA_Human | 1.16692240 |
| 88 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.15974966 |
| 89 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.15854906 |
| 90 | SA1_27219007_Chip-Seq_Bcells_Human | 1.15742370 |
| 91 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.15244121 |
| 92 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.14279892 |
| 93 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.12855141 |
| 94 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.12664138 |
| 95 | MAF_26560356_Chip-Seq_TH2_Human | 1.12214896 |
| 96 | GATA2_19941826_ChIP-Seq_K562_Human | 1.12080213 |
| 97 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.11582671 |
| 98 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.11494140 |
| 99 | MYC_22102868_ChIP-Seq_BL_Human | 1.10491783 |
| 100 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.09940238 |
| 101 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.09656106 |
| 102 | * SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.09606423 |
| 103 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.09099933 |
| 104 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07815087 |
| 105 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.07154658 |
| 106 | PHF8_20622854_ChIP-Seq_HELA_Human | 1.06805527 |
| 107 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.06548949 |
| 108 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.05481096 |
| 109 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.05234344 |
| 110 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 1.05069492 |
| 111 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.04701221 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04272990 |
| 113 | * CTCF_20526341_ChIP-Seq_ESCs_Human | 1.03543392 |
| 114 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.03337431 |
| 115 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.02833641 |
| 116 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.02799644 |
| 117 | STAT3_23295773_ChIP-Seq_U87_Human | 1.02757595 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.01237081 |
| 119 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.01155786 |
| 120 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.00939984 |
| 121 | STAT1_20625510_ChIP-Seq_HELA_Human | 1.00781039 |
| 122 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.00559365 |
| 123 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.00208955 |
| 124 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99262978 |
| 125 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.99009346 |
| 126 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 0.98928599 |
| 127 | ZNF274_21170338_ChIP-Seq_K562_Hela | 0.98693793 |
| 128 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.97718884 |
| 129 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96263481 |
| 130 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.96169529 |
| 131 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.95779242 |
| 132 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.95492214 |
| 133 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.95339008 |
| 134 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.94810199 |
| 135 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.94620691 |
| 136 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.94590458 |
| 137 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 0.94325371 |
| 138 | TAF15_26573619_Chip-Seq_HEK293_Human | 0.94214994 |
| 139 | * PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.93773773 |
| 140 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.93161984 |
| 141 | AR_25329375_ChIP-Seq_VCAP_Human | 0.92452214 |
| 142 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.91167017 |
| 143 | * CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.90951892 |
| 144 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.90889158 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.90141320 |
| 146 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.88843836 |
| 147 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.88452482 |
| 148 | KLF4_19829295_ChIP-Seq_ESCs_Human | 0.88273895 |
| 149 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 0.88262236 |
| 150 | RXR_22108803_ChIP-Seq_LS180_Human | 0.87930570 |
| 151 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.85791967 |
| 152 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.85654562 |
| 153 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 0.85230409 |
| 154 | SMC4_20622854_ChIP-Seq_HELA_Human | 0.84469792 |
| 155 | P300_19829295_ChIP-Seq_ESCs_Human | 0.84304253 |
| 156 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 0.83594060 |
| 157 | TCF4_23295773_ChIP-Seq_U87_Human | 0.82492221 |
| 158 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.81899529 |
| 159 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.81536864 |
| 160 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.81157632 |
| 161 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.80911982 |
| 162 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.78996211 |
| 163 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.78318137 |
| 164 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.78245028 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 6.04754269 |
| 2 | MP0002822_catalepsy | 4.48871285 |
| 3 | MP0003880_abnormal_central_pattern | 3.74077042 |
| 4 | MP0003635_abnormal_synaptic_transmissio | 3.71694921 |
| 5 | MP0004270_analgesia | 3.46983846 |
| 6 | MP0009745_abnormal_behavioral_response | 3.14076416 |
| 7 | MP0002063_abnormal_learning/memory/cond | 3.00413398 |
| 8 | MP0003436_decreased_susceptibility_to | 2.91158582 |
| 9 | MP0002064_seizures | 2.86032580 |
| 10 | MP0005551_abnormal_eye_electrophysiolog | 2.82557309 |
| 11 | MP0005423_abnormal_somatic_nervous | 2.55786769 |
| 12 | MP0009046_muscle_twitch | 2.45228287 |
| 13 | MP0002572_abnormal_emotion/affect_behav | 2.41911637 |
| 14 | MP0003724_increased_susceptibility_to | 2.40452927 |
| 15 | MP0001968_abnormal_touch/_nociception | 2.31097821 |
| 16 | MP0003303_peritoneal_inflammation | 2.28705690 |
| 17 | MP0001486_abnormal_startle_reflex | 2.27942120 |
| 18 | MP0002272_abnormal_nervous_system | 2.25194144 |
| 19 | MP0005360_urolithiasis | 2.14921893 |
| 20 | MP0002734_abnormal_mechanical_nocicepti | 2.12513136 |
| 21 | MP0003183_abnormal_peptide_metabolism | 2.10566986 |
| 22 | MP0001501_abnormal_sleep_pattern | 2.08729671 |
| 23 | MP0009780_abnormal_chondrocyte_physiolo | 2.07023234 |
| 24 | MP0002909_abnormal_adrenal_gland | 2.04726845 |
| 25 | MP0003329_amyloid_beta_deposits | 2.00421180 |
| 26 | MP0003011_delayed_dark_adaptation | 1.91422421 |
| 27 | MP0001790_abnormal_immune_system | 1.84411387 |
| 28 | MP0005387_immune_system_phenotype | 1.84411387 |
| 29 | MP0001835_abnormal_antigen_presentation | 1.84240270 |
| 30 | MP0002653_abnormal_ependyma_morphology | 1.79662457 |
| 31 | MP0002139_abnormal_hepatobiliary_system | 1.79034268 |
| 32 | MP0001440_abnormal_grooming_behavior | 1.72863804 |
| 33 | MP0005000_abnormal_immune_tolerance | 1.70394507 |
| 34 | MP0005025_abnormal_response_to | 1.69709089 |
| 35 | MP0002419_abnormal_innate_immunity | 1.69552551 |
| 36 | MP0005671_abnormal_response_to | 1.66860775 |
| 37 | MP0002733_abnormal_thermal_nociception | 1.63476305 |
| 38 | MP0001800_abnormal_humoral_immune | 1.63251315 |
| 39 | MP0004885_abnormal_endolymph | 1.62758253 |
| 40 | MP0005310_abnormal_salivary_gland | 1.62626932 |
| 41 | MP0000685_abnormal_immune_system | 1.60745808 |
| 42 | MP0005085_abnormal_gallbladder_physiolo | 1.60215674 |
| 43 | MP0001970_abnormal_pain_threshold | 1.59235286 |
| 44 | MP0002736_abnormal_nociception_after | 1.59195848 |
| 45 | MP0006082_CNS_inflammation | 1.58549107 |
| 46 | MP0001986_abnormal_taste_sensitivity | 1.56571226 |
| 47 | MP0005253_abnormal_eye_physiology | 1.55085821 |
| 48 | MP0002735_abnormal_chemical_nociception | 1.53958617 |
| 49 | MP0003866_abnormal_defecation | 1.52482087 |
| 50 | MP0002723_abnormal_immune_serum | 1.51651792 |
| 51 | MP0004924_abnormal_behavior | 1.51477492 |
| 52 | MP0005386_behavior/neurological_phenoty | 1.51477492 |
| 53 | MP0002067_abnormal_sensory_capabilities | 1.51065876 |
| 54 | MP0004858_abnormal_nervous_system | 1.50874436 |
| 55 | MP0002090_abnormal_vision | 1.50437872 |
| 56 | MP0008569_lethality_at_weaning | 1.50388836 |
| 57 | MP0003879_abnormal_hair_cell | 1.49996639 |
| 58 | MP0002229_neurodegeneration | 1.48136376 |
| 59 | MP0001984_abnormal_olfaction | 1.47367548 |
| 60 | MP0005058_abnormal_lysosome_morphology | 1.46934045 |
| 61 | MP0010155_abnormal_intestine_physiology | 1.45281042 |
| 62 | MP0006072_abnormal_retinal_apoptosis | 1.43951340 |
| 63 | MP0004811_abnormal_neuron_physiology | 1.42190363 |
| 64 | MP0002420_abnormal_adaptive_immunity | 1.42131678 |
| 65 | MP0001819_abnormal_immune_cell | 1.41595845 |
| 66 | MP0001502_abnormal_circadian_rhythm | 1.40081546 |
| 67 | MP0005646_abnormal_pituitary_gland | 1.39575796 |
| 68 | MP0002557_abnormal_social/conspecific_i | 1.39102974 |
| 69 | MP0005365_abnormal_bile_salt | 1.36915585 |
| 70 | MP0002452_abnormal_antigen_presenting | 1.36727503 |
| 71 | MP0004043_abnormal_pH_regulation | 1.36470069 |
| 72 | MP0008260_abnormal_autophagy | 1.35666265 |
| 73 | MP0003633_abnormal_nervous_system | 1.35171465 |
| 74 | MP0008961_abnormal_basal_metabolism | 1.35069780 |
| 75 | MP0001348_abnormal_lacrimal_gland | 1.34365794 |
| 76 | MP0003075_altered_response_to | 1.33384061 |
| 77 | MP0002882_abnormal_neuron_morphology | 1.33124029 |
| 78 | MP0008875_abnormal_xenobiotic_pharmacok | 1.31654823 |
| 79 | MP0001533_abnormal_skeleton_physiology | 1.25497832 |
| 80 | MP0009785_altered_susceptibility_to | 1.25325449 |
| 81 | MP0004147_increased_porphyrin_level | 1.21501335 |
| 82 | MP0002066_abnormal_motor_capabilities/c | 1.21289304 |
| 83 | MP0001873_stomach_inflammation | 1.21120233 |
| 84 | MP0005535_abnormal_body_temperature | 1.19740270 |
| 85 | MP0003283_abnormal_digestive_organ | 1.18772393 |
| 86 | MP0001529_abnormal_vocalization | 1.18335754 |
| 87 | MP0005464_abnormal_platelet_physiology | 1.18159187 |
| 88 | MP0002184_abnormal_innervation | 1.17378157 |
| 89 | MP0000604_amyloidosis | 1.16866461 |
| 90 | MP0000955_abnormal_spinal_cord | 1.16525302 |
| 91 | MP0003045_fibrosis | 1.16455091 |
| 92 | MP0002148_abnormal_hypersensitivity_rea | 1.14670658 |
| 93 | MP0004947_skin_inflammation | 1.12505467 |
| 94 | MP0010329_abnormal_lipoprotein_level | 1.12259051 |
| 95 | MP0000678_abnormal_parathyroid_gland | 1.11796255 |
| 96 | MP0003690_abnormal_glial_cell | 1.08835660 |
| 97 | MP0004381_abnormal_hair_follicle | 1.08165803 |
| 98 | MP0000778_abnormal_nervous_system | 1.07663605 |
| 99 | MP0005083_abnormal_biliary_tract | 1.06589235 |
| 100 | MP0003787_abnormal_imprinting | 1.05772503 |
| 101 | MP0001845_abnormal_inflammatory_respons | 1.05071282 |
| 102 | MP0003631_nervous_system_phenotype | 1.03857541 |
| 103 | MP0008874_decreased_physiological_sensi | 1.03281497 |
| 104 | MP0010234_abnormal_vibrissa_follicle | 1.01759222 |
| 105 | MP0008872_abnormal_physiological_respon | 1.01419165 |
| 106 | MP0002069_abnormal_eating/drinking_beha | 1.00853087 |
| 107 | MP0003656_abnormal_erythrocyte_physiolo | 1.00384227 |
| 108 | MP0003763_abnormal_thymus_physiology | 0.98971406 |
| 109 | MP0001664_abnormal_digestion | 0.98426169 |
| 110 | MP0000716_abnormal_immune_system | 0.98073805 |
| 111 | MP0005167_abnormal_blood-brain_barrier | 0.96843831 |
| 112 | MP0005195_abnormal_posterior_eye | 0.96383981 |
| 113 | MP0004742_abnormal_vestibular_system | 0.96131180 |
| 114 | MP0003252_abnormal_bile_duct | 0.95687748 |
| 115 | MP0000015_abnormal_ear_pigmentation | 0.95589897 |
| 116 | MP0001663_abnormal_digestive_system | 0.95152352 |
| 117 | MP0004510_myositis | 0.94604324 |
| 118 | MP0004142_abnormal_muscle_tone | 0.93483611 |
| 119 | MP0001905_abnormal_dopamine_level | 0.92359585 |
| 120 | MP0000013_abnormal_adipose_tissue | 0.91202053 |
| 121 | MP0006276_abnormal_autonomic_nervous | 0.91019648 |
| 122 | MP0002277_abnormal_respiratory_mucosa | 0.90790805 |
| 123 | MP0001177_atelectasis | 0.90379427 |
| 124 | MP0005166_decreased_susceptibility_to | 0.89503483 |
| 125 | MP0002132_abnormal_respiratory_system | 0.87867638 |
| 126 | MP0002398_abnormal_bone_marrow | 0.87804022 |
| 127 | MP0004019_abnormal_vitamin_homeostasis | 0.85972325 |
| 128 | MP0004085_abnormal_heartbeat | 0.85301921 |
| 129 | MP0003634_abnormal_glial_cell | 0.85038217 |
| 130 | MP0009278_abnormal_bone_marrow | 0.84014105 |
| 131 | MP0009764_decreased_sensitivity_to | 0.83380465 |
| 132 | MP0005451_abnormal_body_composition | 0.82890167 |
| 133 | MP0001765_abnormal_ion_homeostasis | 0.82399258 |
| 134 | MP0001666_abnormal_nutrient_absorption | 0.82250058 |
| 135 | MP0009333_abnormal_splenocyte_physiolog | 0.82124496 |
| 136 | MP0002152_abnormal_brain_morphology | 0.80457054 |
| 137 | MP0000920_abnormal_myelination | 0.80324600 |
| 138 | MP0002752_abnormal_somatic_nervous | 0.79809467 |
| 139 | MP0003195_calcinosis | 0.78740706 |
| 140 | MP0002638_abnormal_pupillary_reflex | 0.75813834 |
| 141 | MP0005332_abnormal_amino_acid | 0.75355827 |
| 142 | MP0002118_abnormal_lipid_homeostasis | 0.74960362 |
| 143 | MP0002876_abnormal_thyroid_physiology | 0.74168674 |
| 144 | MP0004130_abnormal_muscle_cell | 0.70244757 |
| 145 | MP0009840_abnormal_foam_cell | 0.69955334 |
| 146 | MP0003172_abnormal_lysosome_physiology | 0.69944792 |
| 147 | MP0010386_abnormal_urinary_bladder | 0.69226423 |
| 148 | MP0002078_abnormal_glucose_homeostasis | 0.68763267 |
| 149 | MP0000751_myopathy | 0.68319513 |
| 150 | MP0005645_abnormal_hypothalamus_physiol | 0.68154849 |
| 151 | MP0005448_abnormal_energy_balance | 0.66598326 |
| 152 | MP0001324_abnormal_eye_pigmentation | 0.66019354 |
| 153 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.65836792 |
| 154 | MP0003632_abnormal_nervous_system | 0.64206317 |
| 155 | MP0002837_dystrophic_cardiac_calcinosis | 0.64090176 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Myokymia (HP:0002411) | 6.19845567 |
| 2 | Focal motor seizures (HP:0011153) | 5.85244123 |
| 3 | Focal seizures (HP:0007359) | 4.55349368 |
| 4 | Visual hallucinations (HP:0002367) | 4.46723199 |
| 5 | Congenital stationary night blindness (HP:0007642) | 4.46037317 |
| 6 | Central scotoma (HP:0000603) | 4.14958952 |
| 7 | Eczematoid dermatitis (HP:0000976) | 3.88031504 |
| 8 | Recurrent bacterial skin infections (HP:0005406) | 3.78072234 |
| 9 | Dynein arm defect of respiratory motile cilia (HP:0012255) | 3.75198632 |
| 10 | Absent/shortened dynein arms (HP:0200106) | 3.75198632 |
| 11 | Bony spicule pigmentary retinopathy (HP:0007737) | 3.67832423 |
| 12 | Epileptic encephalopathy (HP:0200134) | 3.60798388 |
| 13 | Recurrent abscess formation (HP:0002722) | 3.59909360 |
| 14 | Pigmentary retinal degeneration (HP:0001146) | 3.55588158 |
| 15 | Respiratory insufficiency due to defective ciliary clearance (HP:0200073) | 3.53363939 |
| 16 | Abnormality of macular pigmentation (HP:0008002) | 3.43077570 |
| 17 | Abnormality of binocular vision (HP:0011514) | 3.39396999 |
| 18 | Diplopia (HP:0000651) | 3.39396999 |
| 19 | Nasal polyposis (HP:0100582) | 3.30829613 |
| 20 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 3.30358919 |
| 21 | Supranuclear gaze palsy (HP:0000605) | 3.29723353 |
| 22 | Abnormal respiratory motile cilium morphology (HP:0005938) | 3.24231216 |
| 23 | Abnormal respiratory epithelium morphology (HP:0012253) | 3.24231216 |
| 24 | Absence seizures (HP:0002121) | 3.21567952 |
| 25 | Action tremor (HP:0002345) | 3.21292183 |
| 26 | Abnormal rod and cone electroretinograms (HP:0008323) | 3.20951220 |
| 27 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 3.20060789 |
| 28 | Generalized tonic-clonic seizures (HP:0002069) | 3.18273991 |
| 29 | Scotoma (HP:0000575) | 3.17113301 |
| 30 | Progressive cerebellar ataxia (HP:0002073) | 3.12110602 |
| 31 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.10142377 |
| 32 | Myositis (HP:0100614) | 3.09708395 |
| 33 | Febrile seizures (HP:0002373) | 3.05165379 |
| 34 | Increased cerebral lipofuscin (HP:0011813) | 3.04553290 |
| 35 | Abnormal respiratory motile cilium physiology (HP:0012261) | 3.03986338 |
| 36 | Atonic seizures (HP:0010819) | 3.02204634 |
| 37 | Dyschromatopsia (HP:0007641) | 3.00487502 |
| 38 | Dysdiadochokinesis (HP:0002075) | 2.99773300 |
| 39 | Abnormal ciliary motility (HP:0012262) | 2.98720910 |
| 40 | Abnormality of macrophages (HP:0004311) | 2.97688776 |
| 41 | Dialeptic seizures (HP:0011146) | 2.96140499 |
| 42 | Impaired social interactions (HP:0000735) | 2.96069626 |
| 43 | Abnormal social behavior (HP:0012433) | 2.96069626 |
| 44 | Depression (HP:0000716) | 2.95908571 |
| 45 | Postural instability (HP:0002172) | 2.93630072 |
| 46 | Torticollis (HP:0000473) | 2.92596723 |
| 47 | Abnormality of the lower motor neuron (HP:0002366) | 2.92368474 |
| 48 | Stomatitis (HP:0010280) | 2.90132417 |
| 49 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 2.89969634 |
| 50 | Poor eye contact (HP:0000817) | 2.89791555 |
| 51 | Abnormality of the nasal mucosa (HP:0000433) | 2.85486991 |
| 52 | Orchitis (HP:0100796) | 2.82770025 |
| 53 | Anxiety (HP:0000739) | 2.82757981 |
| 54 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.80464730 |
| 55 | Chorioretinal atrophy (HP:0000533) | 2.80343120 |
| 56 | Obstructive sleep apnea (HP:0002870) | 2.80099058 |
| 57 | Ankle clonus (HP:0011448) | 2.77836928 |
| 58 | Dysmetria (HP:0001310) | 2.77181271 |
| 59 | Agitation (HP:0000713) | 2.76094618 |
| 60 | Optic neuritis (HP:0100653) | 2.72315270 |
| 61 | Retrobulbar optic neuritis (HP:0100654) | 2.72315270 |
| 62 | Abolished electroretinogram (ERG) (HP:0000550) | 2.70646405 |
| 63 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.68475813 |
| 64 | Focal dystonia (HP:0004373) | 2.62193944 |
| 65 | Neurofibrillary tangles (HP:0002185) | 2.57042768 |
| 66 | Broad-based gait (HP:0002136) | 2.56737654 |
| 67 | Hyperventilation (HP:0002883) | 2.56065377 |
| 68 | Truncal ataxia (HP:0002078) | 2.55192452 |
| 69 | Status epilepticus (HP:0002133) | 2.54612997 |
| 70 | Cerebral inclusion bodies (HP:0100314) | 2.54295365 |
| 71 | Craniofacial dystonia (HP:0012179) | 2.49481666 |
| 72 | Decreased central vision (HP:0007663) | 2.49174003 |
| 73 | Intention tremor (HP:0002080) | 2.48480811 |
| 74 | Abnormal eating behavior (HP:0100738) | 2.47359399 |
| 75 | Recurrent fungal infections (HP:0002841) | 2.44796905 |
| 76 | Gaze-evoked nystagmus (HP:0000640) | 2.43702755 |
| 77 | Bronchiectasis (HP:0002110) | 2.42392625 |
| 78 | Mediastinal lymphadenopathy (HP:0100721) | 2.40502142 |
| 79 | Recurrent skin infections (HP:0001581) | 2.39482122 |
| 80 | Mutism (HP:0002300) | 2.37162214 |
| 81 | Pustule (HP:0200039) | 2.36450838 |
| 82 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.33163164 |
| 83 | Genetic anticipation (HP:0003743) | 2.33059431 |
| 84 | Increased circulating renin level (HP:0000848) | 2.32783826 |
| 85 | Decreased circulating renin level (HP:0003351) | 2.32388103 |
| 86 | Amblyopia (HP:0000646) | 2.32232824 |
| 87 | Spastic gait (HP:0002064) | 2.31936799 |
| 88 | Ventricular fibrillation (HP:0001663) | 2.31193500 |
| 89 | Chronic obstructive pulmonary disease (HP:0006510) | 2.29765700 |
| 90 | Obstructive lung disease (HP:0006536) | 2.29765700 |
| 91 | Retinal atrophy (HP:0001105) | 2.29644473 |
| 92 | Urinary urgency (HP:0000012) | 2.29573602 |
| 93 | Rhinitis (HP:0012384) | 2.28541853 |
| 94 | Gastrointestinal infarctions (HP:0005244) | 2.28083598 |
| 95 | Bradykinesia (HP:0002067) | 2.24033754 |
| 96 | Type II diabetes mellitus (HP:0005978) | 2.23302421 |
| 97 | Dysostosis multiplex (HP:0000943) | 2.22911923 |
| 98 | Recurrent sinusitis (HP:0011108) | 2.22117226 |
| 99 | Hemiplegia (HP:0002301) | 2.21989221 |
| 100 | Papilledema (HP:0001085) | 2.19814635 |
| 101 | Dysmetric saccades (HP:0000641) | 2.19492743 |
| 102 | Choroideremia (HP:0001139) | 2.17164685 |
| 103 | Abnormality of glycolipid metabolism (HP:0010969) | 2.16516973 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.16516973 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.16516973 |
| 106 | Scanning speech (HP:0002168) | 2.16430433 |
| 107 | Epileptiform EEG discharges (HP:0011182) | 2.15955448 |
| 108 | Macular degeneration (HP:0000608) | 2.15644465 |
| 109 | Posterior subcapsular cataract (HP:0007787) | 2.14871505 |
| 110 | Impaired smooth pursuit (HP:0007772) | 2.11499492 |
| 111 | Gout (HP:0001997) | 2.10487825 |
| 112 | Decreased electroretinogram (ERG) amplitude (HP:0000654) | 2.09948099 |
| 113 | EEG with generalized epileptiform discharges (HP:0011198) | 2.08394405 |
| 114 | Generalized myoclonic seizures (HP:0002123) | 2.07415332 |
| 115 | Slow saccadic eye movements (HP:0000514) | 2.06877044 |
| 116 | Resting tremor (HP:0002322) | 2.06555654 |
| 117 | Gingivitis (HP:0000230) | 2.05080433 |
| 118 | Annular pancreas (HP:0001734) | 2.05006685 |
| 119 | Hypochromic anemia (HP:0001931) | 2.04256893 |
| 120 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.03725828 |
| 121 | Recurrent cutaneous fungal infections (HP:0011370) | 2.03725828 |
| 122 | Vasculitis (HP:0002633) | 2.03075958 |
| 123 | Impaired vibratory sensation (HP:0002495) | 2.02710585 |
| 124 | Stereotypic behavior (HP:0000733) | 2.02371279 |
| 125 | Drooling (HP:0002307) | 2.01545657 |
| 126 | Excessive salivation (HP:0003781) | 2.01545657 |
| 127 | Hypsarrhythmia (HP:0002521) | 2.01109765 |
| 128 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 2.00484585 |
| 129 | Prolonged bleeding time (HP:0003010) | 1.97988853 |
| 130 | Photophobia (HP:0000613) | 1.93644661 |
| 131 | Pendular nystagmus (HP:0012043) | 1.91645161 |
| 132 | Encephalitis (HP:0002383) | 1.91009651 |
| 133 | Megalencephaly (HP:0001355) | 1.89837671 |
| 134 | Insomnia (HP:0100785) | 1.88483806 |
| 135 | Deep venous thrombosis (HP:0002625) | 1.87564359 |
| 136 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.87233117 |
| 137 | Abnormality of ocular smooth pursuit (HP:0000617) | 1.86271891 |
| 138 | Clumsiness (HP:0002312) | 1.86139467 |
| 139 | Meningitis (HP:0001287) | 1.85910079 |
| 140 | Hemiparesis (HP:0001269) | 1.85270457 |
| 141 | Hyperthyroidism (HP:0000836) | 1.84568766 |
| 142 | Insidious onset (HP:0003587) | 1.84452022 |
| 143 | Termporal pattern (HP:0011008) | 1.84452022 |
| 144 | Attenuation of retinal blood vessels (HP:0007843) | 1.83923850 |
| 145 | Chronic otitis media (HP:0000389) | 1.83628063 |
| 146 | Lower limb muscle weakness (HP:0007340) | 1.82845710 |
| 147 | Recurrent otitis media (HP:0000403) | 1.82797990 |
| 148 | Clonus (HP:0002169) | 1.82735962 |
| 149 | Rigidity (HP:0002063) | 1.82649215 |
| 150 | Spontaneous hematomas (HP:0007420) | 1.81995208 |
| 151 | Absent speech (HP:0001344) | 1.81852168 |
| 152 | Neuronal loss in central nervous system (HP:0002529) | 1.81442066 |
| 153 | Pheochromocytoma (HP:0002666) | 1.81138032 |
| 154 | Hemoptysis (HP:0002105) | 1.80138853 |
| 155 | Episodic fever (HP:0001954) | 1.80138626 |
| 156 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.79666799 |
| 157 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.79666799 |
| 158 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.79666799 |
| 159 | Global brain atrophy (HP:0002283) | 1.79315408 |
| 160 | Increased IgE level (HP:0003212) | 1.79305707 |
| 161 | Abnormality of the corticospinal tract (HP:0002492) | 1.78892663 |
| 162 | Memory impairment (HP:0002354) | 1.78538455 |
| 163 | Blue irides (HP:0000635) | 1.78494827 |
| 164 | Abnormal EKG (HP:0003115) | 1.78063907 |
| 165 | Progressive visual loss (HP:0000529) | 1.77249821 |
| 166 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.77134838 |
| 167 | Bundle branch block (HP:0011710) | 1.76635621 |
| 168 | Hypochromic microcytic anemia (HP:0004840) | 1.76283219 |
| 169 | Ocular albinism (HP:0001107) | 1.76221280 |
| 170 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 1.76192607 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 5.36331613 |
| 2 | NTRK3 | 4.23029179 |
| 3 | MAP3K9 | 3.60036331 |
| 4 | DAPK2 | 2.67202061 |
| 5 | PRKD3 | 2.63859160 |
| 6 | KSR2 | 2.58501431 |
| 7 | MAP4K1 | 2.39376408 |
| 8 | MAP3K4 | 2.23567661 |
| 9 | MINK1 | 2.20902518 |
| 10 | CAMKK1 | 2.09961447 |
| 11 | PAK6 | 2.07932717 |
| 12 | MARK1 | 1.98680366 |
| 13 | ERN1 | 1.94154031 |
| 14 | NTRK1 | 1.93230238 |
| 15 | RIPK4 | 1.85997464 |
| 16 | MAP3K2 | 1.83306030 |
| 17 | MAP3K11 | 1.79823814 |
| 18 | GRK6 | 1.77142290 |
| 19 | BLK | 1.72309492 |
| 20 | NTRK2 | 1.69615406 |
| 21 | MAP2K4 | 1.68402776 |
| 22 | SIK2 | 1.62339781 |
| 23 | FES | 1.57645899 |
| 24 | CDK5 | 1.53770573 |
| 25 | KSR1 | 1.53748567 |
| 26 | MAP2K3 | 1.53730478 |
| 27 | MAP2K7 | 1.53508285 |
| 28 | TYK2 | 1.52649248 |
| 29 | MAP3K13 | 1.45105222 |
| 30 | STK38 | 1.41177457 |
| 31 | TAOK1 | 1.40600220 |
| 32 | ZAP70 | 1.35179214 |
| 33 | ARAF | 1.33313667 |
| 34 | IRAK4 | 1.32327531 |
| 35 | PINK1 | 1.32114849 |
| 36 | CSK | 1.30730099 |
| 37 | GRK5 | 1.26257278 |
| 38 | PRKCH | 1.24532386 |
| 39 | DAPK1 | 1.22585765 |
| 40 | SGK494 | 1.14740638 |
| 41 | SGK223 | 1.14740638 |
| 42 | TYRO3 | 1.10536180 |
| 43 | PRKCG | 1.08932033 |
| 44 | PRPF4B | 1.08860700 |
| 45 | SYK | 1.07209331 |
| 46 | BMPR2 | 1.06341997 |
| 47 | CAMK1D | 1.05635599 |
| 48 | TNIK | 1.04030599 |
| 49 | SIK1 | 1.03359870 |
| 50 | MAP2K6 | 1.01972934 |
| 51 | STK11 | 1.00826216 |
| 52 | BTK | 1.00798807 |
| 53 | MARK2 | 0.97914644 |
| 54 | PDPK1 | 0.97824495 |
| 55 | MAPK15 | 0.97098926 |
| 56 | GRK1 | 0.96756693 |
| 57 | MAP3K1 | 0.96413221 |
| 58 | UHMK1 | 0.96121007 |
| 59 | SGK3 | 0.93925715 |
| 60 | EPHB1 | 0.92805255 |
| 61 | CAMKK2 | 0.91308228 |
| 62 | RET | 0.91108950 |
| 63 | CAMK2A | 0.90827686 |
| 64 | JAK2 | 0.90140972 |
| 65 | PDK1 | 0.89844124 |
| 66 | HCK | 0.86330123 |
| 67 | CAMK1 | 0.86276691 |
| 68 | RPS6KA2 | 0.85392258 |
| 69 | SGK2 | 0.84957306 |
| 70 | SMG1 | 0.84355494 |
| 71 | JAK1 | 0.84019895 |
| 72 | INSRR | 0.82533207 |
| 73 | SGK1 | 0.81140382 |
| 74 | MAP3K3 | 0.81061889 |
| 75 | PTK2B | 0.80240022 |
| 76 | PNCK | 0.79823115 |
| 77 | CAMK2B | 0.79472323 |
| 78 | ITK | 0.78711003 |
| 79 | OXSR1 | 0.78057241 |
| 80 | PRKCZ | 0.76059297 |
| 81 | ACVR1B | 0.74587014 |
| 82 | MAP3K7 | 0.73957584 |
| 83 | TXK | 0.72943844 |
| 84 | WNK4 | 0.72726818 |
| 85 | TRIB3 | 0.72252197 |
| 86 | ALK | 0.72057934 |
| 87 | PLK2 | 0.71769552 |
| 88 | SIK3 | 0.71631620 |
| 89 | HIPK2 | 0.71487641 |
| 90 | CDK15 | 0.71117151 |
| 91 | CAMK1G | 0.69847190 |
| 92 | CDK18 | 0.69691033 |
| 93 | TBK1 | 0.69073212 |
| 94 | IKBKE | 0.68848494 |
| 95 | PAK3 | 0.68694831 |
| 96 | RAF1 | 0.68586072 |
| 97 | CDK14 | 0.67841272 |
| 98 | MAP3K6 | 0.67602160 |
| 99 | RIPK1 | 0.67436053 |
| 100 | PTK6 | 0.67075755 |
| 101 | IRAK3 | 0.66250665 |
| 102 | MAP3K12 | 0.63276475 |
| 103 | PHKG2 | 0.63242651 |
| 104 | PHKG1 | 0.63242651 |
| 105 | ICK | 0.63030663 |
| 106 | MAPK13 | 0.63003685 |
| 107 | LCK | 0.62153331 |
| 108 | CSNK1G2 | 0.61074681 |
| 109 | SCYL2 | 0.60828918 |
| 110 | CDC42BPA | 0.60444632 |
| 111 | CDK11A | 0.59324906 |
| 112 | RPS6KA3 | 0.58510478 |
| 113 | MAP2K2 | 0.55710292 |
| 114 | MAP2K1 | 0.55173578 |
| 115 | MAPKAPK3 | 0.54516138 |
| 116 | PKN2 | 0.54306472 |
| 117 | LYN | 0.53784511 |
| 118 | MATK | 0.53256880 |
| 119 | LMTK2 | 0.53175269 |
| 120 | PRKD2 | 0.52887698 |
| 121 | TNK2 | 0.52141513 |
| 122 | ERBB2 | 0.52006844 |
| 123 | DYRK1A | 0.51642464 |
| 124 | IRAK1 | 0.51432961 |
| 125 | CAMK2D | 0.50614153 |
| 126 | FYN | 0.50232174 |
| 127 | WNK3 | 0.49328261 |
| 128 | TAOK3 | 0.48922475 |
| 129 | RPS6KA6 | 0.48553231 |
| 130 | CAMK2G | 0.47168183 |
| 131 | PRKCQ | 0.46978465 |
| 132 | FRK | 0.46970826 |
| 133 | MAPK12 | 0.46457657 |
| 134 | IRAK2 | 0.45983120 |
| 135 | CAMK4 | 0.45766031 |
| 136 | FGFR2 | 0.45360390 |
| 137 | WNK1 | 0.45302465 |
| 138 | PRKACG | 0.43799089 |
| 139 | AKT3 | 0.43474857 |
| 140 | CDK19 | 0.43393157 |
| 141 | FER | 0.42730552 |
| 142 | MAPK10 | 0.41735537 |
| 143 | PRKCB | 0.40425026 |
| 144 | PRKCE | 0.39708612 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 3.67863413 |
| 2 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.78520785 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 2.63582614 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.62238914 |
| 5 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.60684376 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.40452560 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.22884124 |
| 8 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.11112163 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.10138369 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.10132867 |
| 11 | Long-term potentiation_Homo sapiens_hsa04720 | 2.10021303 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 2.06537654 |
| 13 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 2.03694389 |
| 14 | Insulin secretion_Homo sapiens_hsa04911 | 1.86915255 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.82502765 |
| 16 | Salivary secretion_Homo sapiens_hsa04970 | 1.74232244 |
| 17 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.73606448 |
| 18 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.70094333 |
| 19 | Cocaine addiction_Homo sapiens_hsa05030 | 1.69782723 |
| 20 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.63102334 |
| 21 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.61202843 |
| 22 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.58669457 |
| 23 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.55003167 |
| 24 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.53332843 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.47832430 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.46297061 |
| 27 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.43776034 |
| 28 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.39358606 |
| 29 | Renin secretion_Homo sapiens_hsa04924 | 1.38813014 |
| 30 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.34917640 |
| 31 | Bile secretion_Homo sapiens_hsa04976 | 1.34847689 |
| 32 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.33749540 |
| 33 | Leishmaniasis_Homo sapiens_hsa05140 | 1.31197838 |
| 34 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28416655 |
| 35 | Tuberculosis_Homo sapiens_hsa05152 | 1.25390072 |
| 36 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.24686113 |
| 37 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.21728049 |
| 38 | Taste transduction_Homo sapiens_hsa04742 | 1.19779251 |
| 39 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.19709558 |
| 40 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 1.19284315 |
| 41 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.18319020 |
| 42 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.16790138 |
| 43 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.16193764 |
| 44 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.15036170 |
| 45 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.12816549 |
| 46 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.12265228 |
| 47 | Long-term depression_Homo sapiens_hsa04730 | 1.11001891 |
| 48 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.10467799 |
| 49 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06292440 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.06062887 |
| 51 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.01695036 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 0.99922622 |
| 53 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.99651552 |
| 54 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.96417519 |
| 55 | Gap junction_Homo sapiens_hsa04540 | 0.95282392 |
| 56 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.95038715 |
| 57 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.93996625 |
| 58 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.92681506 |
| 59 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.91379797 |
| 60 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.91024171 |
| 61 | Other glycan degradation_Homo sapiens_hsa00511 | 0.90555489 |
| 62 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.87950995 |
| 63 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.87832586 |
| 64 | Glioma_Homo sapiens_hsa05214 | 0.86419829 |
| 65 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.86151988 |
| 66 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.84420783 |
| 67 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.84222357 |
| 68 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.82815136 |
| 69 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82382014 |
| 70 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.80434327 |
| 71 | Allograft rejection_Homo sapiens_hsa05330 | 0.79779838 |
| 72 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.79739831 |
| 73 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.79125102 |
| 74 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.77210484 |
| 75 | Lysosome_Homo sapiens_hsa04142 | 0.76719876 |
| 76 | Hepatitis C_Homo sapiens_hsa05160 | 0.73891639 |
| 77 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.73230768 |
| 78 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.72874602 |
| 79 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72098558 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.67872182 |
| 81 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.67648546 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.66687458 |
| 83 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.66013409 |
| 84 | Platelet activation_Homo sapiens_hsa04611 | 0.65383395 |
| 85 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.65106962 |
| 86 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.63577587 |
| 87 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.63530672 |
| 88 | Histidine metabolism_Homo sapiens_hsa00340 | 0.63035229 |
| 89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62640387 |
| 90 | Phagosome_Homo sapiens_hsa04145 | 0.61914988 |
| 91 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.61759550 |
| 92 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.61705009 |
| 93 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.61536953 |
| 94 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.61526313 |
| 95 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.59688047 |
| 96 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.58963778 |
| 97 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.58280270 |
| 98 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.58203190 |
| 99 | Axon guidance_Homo sapiens_hsa04360 | 0.57843656 |
| 100 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.57103755 |
| 101 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.56970589 |
| 102 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.54775437 |
| 103 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.54711995 |
| 104 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.53785366 |
| 105 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.53049184 |
| 106 | Prion diseases_Homo sapiens_hsa05020 | 0.52278654 |
| 107 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.51455348 |
| 108 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.50764843 |
| 109 | Circadian rhythm_Homo sapiens_hsa04710 | 0.50026169 |
| 110 | ABC transporters_Homo sapiens_hsa02010 | 0.47832090 |
| 111 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.45956267 |
| 112 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.45603824 |
| 113 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.45350572 |
| 114 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.45284173 |
| 115 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.45118505 |
| 116 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.44680968 |
| 117 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.44566755 |
| 118 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.43373487 |
| 119 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.43340402 |
| 120 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.41889663 |
| 121 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.41776247 |
| 122 | Mineral absorption_Homo sapiens_hsa04978 | 0.40714763 |
| 123 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38373898 |
| 124 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.37664776 |
| 125 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.35136449 |
| 126 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.34820728 |
| 127 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.34729375 |
| 128 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.33284784 |
| 129 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.32881761 |
| 130 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.31686304 |
| 131 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.31631532 |
| 132 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.30454773 |
| 133 | Endocytosis_Homo sapiens_hsa04144 | 0.29780727 |
| 134 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.29138190 |
| 135 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.28998836 |
| 136 | Insulin resistance_Homo sapiens_hsa04931 | 0.26469491 |
| 137 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.25637748 |
| 138 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.25576412 |
| 139 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.25435281 |

